Bruker Corp

NAS:BRKRHealthcareNASDAQ:NCXNASDAQ:NQUSSG

$56.10+1.32%LiveIn session · ≈ AED 206.03 · Market cap $8.55B · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	47.3%	50.0%	51.6%	51.0%	49.0%	45.9%	—	—
Operating margin	12.5%	17.1%	17.1%	14.7%	7.5%	6.9%	6.9%	+0.0 pts
Net margin	7.9%	11.5%	11.7%	14.4%	3.4%	−0.3%	0.8%	+1.1 pts
EBITDA margin	16.1%	20.6%	20.5%	22.8%	13.0%	8.8%	—	—
Return on equity	16.4%	25.9%	26.6%	31.0%	6.3%	−0.4%	1.2%	+1.5 pts
Return on assets	5.2%	7.6%	8.2%	10.1%	1.9%	−0.1%	0.5%	+0.6 pts
Return on capital employed	11.0%	15.2%	16.0%	14.3%	5.6%	4.8%	—	—
Debt / equity	0.9×	1.3×	1.1×	1.0×	1.3×	0.8×	0.8×	−2.1%
Debt / assets	29.9%	38.2%	35.2%	32.5%	38.7%	32.7%	—	—
Interest coverage	17.2×	28.9×	26.9×	26.6×	5.3×	3.9×	—	—
Current ratio	2.4×	2.6×	2.3×	1.8×	1.6×	1.7×	1.7×	+0.0%
Quick ratio	1.6×	1.9×	1.4×	1.0×	0.8×	0.9×	—	—
Cash ratio	0.9×	1.1×	0.7×	0.4×	0.1×	0.2×	0.2×	+0.0%
Asset turnover	0.7×	0.7×	0.7×	0.7×	0.6×	0.6×	—	—
Inventory turnover	1.5×	1.7×	1.5×	1.5×	1.6×	1.7×	—	—
Receivables turnover	5.9×	5.8×	4.3×	4.8×	4.8×	4.7×	—	—
Dividend payout	15.6%	8.7%	10.0%	6.9%	26.7%	−265.1%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.